|
|
||||||||
Ann Thorac Surg 2001;72:1918-1925
© 2001 The Society of Thoracic Surgeons
a Division of Thoracic Surgery, Brigham and Womens Hospital, Boston, Massachusetts, USA
* Address reprint requests to Dr Swanson, Division of Thoracic Surgery, Brigham and Womens Hospital, 75 Francis St, Boston, MA 02115, USA
e-mail: sjswanson{at}partners.org
Presented at the Thirty-seventh Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 2931, 2001.
Background. Several techniques for esophageal resection have been reported. This study examines the morbidity, mortality, and early survival of patients after transthoracic esophagectomy for esophageal carcinoma using current staging techniques and neoadjuvant therapy. The technique includes right thoracotomy, laparotomy, and cervical esophagogastrostomy (total thoracic esophagectomy) with radical mediastinal and abdominal lymph node dissection.
Methods. Three hundred forty-two patients had surgery for esophageal carcinoma between 1989 and 2000 at our institution. Two hundred fifty consecutive patients had esophagectomy using this technique. Kaplan-Meier curves and univariate and multivariate analyses were performed by postsurgical pathologic stage.
Results. Median age was 62.7 years (31 to 86 years). Fifty-nine were female. Eighty-one percent (202) had induction chemotherapy (all patients with clinical T3/4 or N1). Early postoperative complications included recurrent laryngeal nerve injury (14% [35]), chylothorax (9%, [22]), and leak (8%, [19]). Median length of stay was 13 days (5 to 330 days). In-hospital or 30-day mortality was 3.6% (9). Overall survival at 3 years was 44%; median survival was 25 months, and 3-year survival by posttreatment pathologic stage was: stage 0 (complete response) (n = 60), 56%; stage I (n = 32), 65%; stage IIA (n = 67), 41%; stage IIB (n = 30), 46%; and stage III (n = 49), 17%. Mean follow-up was 24 months (SEM 1.6, 0 to 138 months). Five patients with tumor in situ, 6 patients with stage IV disease, and 1 patient who could not be staged (12 pts) were excluded from survival and multivariate calculations. In univariate and different models of multivariate analysis, age more than 65 years, posttreatment T3, and nodal involvement were predictive of poor survival. For univariate analysis, p = 0.002, p = 0.004, p = 0.02, respectively; for multivariate analysis, p = 0.001, p = 0.003, p = 0.02, respectively.
Conclusions. Total thoracic esophagectomy with node dissection for esophageal cancer appears to have acceptable morbidity and mortality with encouraging survival results in the setting of neoadjuvant therapy. Patients who show complete response after induction chemoradiotherapy appear to have improved long-term survival.
This article has been cited by other articles:
![]() |
N. Safieddine, W. Xu, S. M. Quadri, J. J. Knox, J. Hornby, J. Sulman, R. Wong, M. Guindi, S. Keshavjee, and G. Darling Health-related quality of life in esophageal cancer: effect of neoadjuvant chemoradiotherapy followed by surgical intervention. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 36 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Barbour, M. Jones, M. Gonen, D. C. Gotley, J. Thomas, D. B. Thomson, B. Burmeister, and B. M. Smithers Refining Esophageal Cancer Staging After Neoadjuvant Therapy: Importance of Treatment Response Ann. Surg. Oncol., October 1, 2008; 15(10): 2894 - 2902. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Feber, L. Xi, J. D. Luketich, A. Pennathur, R. J. Landreneau, M. Wu, S. J. Swanson, T. E. Godfrey, and V. R. Litle MicroRNA expression profiles of esophageal cancer. J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 255 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pennathur and J. D. Luketich Resection for Esophageal Cancer: Strategies for Optimal Management Ann. Thorac. Surg., February 1, 2008; 85(2): S751 - S756. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Russell, V. H. Thourani, and J. I. Miller Jr Modified Nissen Fundoplication Combined With Ivor Lewis Esophagogastrectomy Ann. Thorac. Surg., November 1, 2007; 84(5): 1780 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Keeley, A. Pennathur, W. Gooding, R. J. Landreneau, N. A. Christie, and J. Luketich Photodynamic Therapy with Curative Intent for Barrett's Esophagus with High Grade Dysplasia and Superficial Esophageal Cancer Ann. Surg. Oncol., August 1, 2007; 14(8): 2406 - 2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Bhat, M. A. Dar, G. N. Lone, and A. M. Dar Use of Pedicled Omentum in Esophagogastric Anastomosis for Prevention of Anastomotic Leak Ann. Thorac. Surg., November 1, 2006; 82(5): 1857 - 1862. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Gaca, R. P. Petersen, B. L. Peterson, D. H. Harpole Jr., T. A. D'Amico, T. N. Pappas, H. F. Seigler, W. G. Wolfe, and D. S. Tyler Pathologic Nodal Status Predicts Disease-Free Survival After Neoadjuvant Chemoradiation for Gastroesophageal Junction Carcinoma Ann. Surg. Oncol., March 1, 2006; 13(3): 340 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Black, J. Niamat, S. Boddu, A. Martin-Ucar, J. P. Duffy, W. E. Morgan, and F. D. Beggs Unplanned splenectomy during oesophagectomy does not affect survival Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 244 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Korst, J. L. Port, P. C. Lee, and N. K. Altorki Intrathoracic Manifestations of Cervical Anastomotic Leaks After Transthoracic Esophagectomy for Carcinoma Ann. Thorac. Surg., October 1, 2005; 80(4): 1185 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Bodner, M. Zitt, H. Ott, G. J. Wetscher, H. Wykypiel, P. Lucciarini, and T. Schmid Robotic-Assisted Thoracoscopic Surgery (RATS) for Benign and Malignant Esophageal Tumors Ann. Thorac. Surg., October 1, 2005; 80(4): 1202 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Natsugoe, H. Okumura, M. Matsumoto, S. Ishigami, T. Owaki, S. Nakano, and T. Aikou Reconstruction of Recurrent Laryngeal Nerve With Involvement by Metastatic Node in Esophageal Cancer Ann. Thorac. Surg., June 1, 2005; 79(6): 1886 - 1889. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Kesler, P. R. Helft, E. A. Werner, N. P. Jain, J. A. Brooks, J. M. DeWitt, J. K. Leblanc, N. S. Fineberg, L. H. Einhorn, and J. W. Brown A Retrospective Analysis of Locally Advanced Esophageal Cancer Patients Treated With Neoadjuvant Chemoradiation Therapy Followed by Surgery or Surgery Alone Ann. Thorac. Surg., April 1, 2005; 79(4): 1116 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mariette, G. Taillier, I. Van Seuningen, and J.-P. Triboulet Factors Affecting Postoperative Course and Survival After En Bloc Resection for Esophageal Carcinoma Ann. Thorac. Surg., October 1, 2004; 78(4): 1177 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Johansson, T. R. DeMeester, J. A. Hagen, S. R. DeMeester, J. H. Peters, S. Oberg, and C. G. Bremner En Bloc vs Transhiatal Esophagectomy for Stage T3 N1 Adenocarcinoma of the Distal Esophagus Arch Surg, June 1, 2004; 139(6): 627 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Enzinger and R. J. Mayer Esophageal Cancer N. Engl. J. Med., December 4, 2003; 349(23): 2241 - 2252. [Full Text] [PDF] |
||||
![]() |
C. Mariette, L. Finzi, S. Fabre, J.-M. Balon, I. Van Seuningen, and J.-P. J. Triboulet Factors predictive of complete resection of operable esophageal cancer: a prospective study Ann. Thorac. Surg., June 1, 2003; 75(6): 1720 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Casson, S. C. Evans, A. Gillis, G. A. Porter, P. Veugelers, S. J. Darnton, D. L. Guernsey, and P. Hainaut Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: Results of a ten-year prospective study J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1121 - 1131. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |